ClinicalTrials.govpublic full text
SHR-A1811 Combine With Pyrotinib for Locally Advanced/Metastatic HER2 Positive Breast Cancer
metastatic breast cancer with her2 positive, shr-a1811, pyrotinib, her2 positive, metastatic breast cancer, locally advanced breast cancer, antibody drug conjugates, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 865957
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.